Hamps Bio Ltd. has announced there is no deviation or variation in the use of funds raised through its Initial Public Offering of Rs. 22.20 lakh.

The funds have been utilized as planned across the purchase of machinery for its FMCG division, brand awareness activities, general corporate purposes, and issue expenses.

The Audit Committee has reviewed and confirmed proper utilization, providing assurance to shareholders that the IPO proceeds are being deployed as intended to support operational and growth initiatives.